Sign In
Buy TEVA
$34.43
-0.0300 (-0.0871%)
At Close: Aug 04, 2026
Why Is F45 Training Holdings Down By 56%? Here Are 28 Stocks Moving In Wednesday's Pre-Market Session
10:34am, Wednesday, 27'th Jul 2022 Benzinga
Gainers
Dave Inc. (NASDAQ: DAVE) rose 56.9% to $0.9826 in pre-market trading. Dave is expected to release its second quarter 2022 financial results on Thursday, August 11, 2022.
Pzena Investment Mana
Teva Pharmaceutical Soars On $75 Million Opioid Deal In West Virginia
09:14am, Wednesday, 27'th Jul 2022
Teva Pharmaceutical will pay $75 million over 15 years and provide free opioid overdose treatment for 10 years. Teva stock rocketed.
Teva's stock jumps 25% after announcing $4.2 billion deal to resolve opioid lawsuits
08:22am, Wednesday, 27'th Jul 2022
Shares of Teva Pharmaceutical Industries Ltd. TEVA, -0.97% soared 25.7% in premarket trading on Wednesday, the day after the company said it will pay $4.25 billion to states, plus an additional $100 m
Why Teva Pharmaceutical Industries Stock Is On Fire Today
08:13am, Wednesday, 27'th Jul 2022
The drugmaker's opioid litigation may soon be resolved.
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits
10:06pm, Tuesday, 26'th Jul 2022
Teva Pharmaceutical Industries on Tuesday announced a $4.35 billion proposed nationwide settlement that could resolve thousands of lawsuits over the drugmaker's alleged role in the US opioid epidemic.
Teva Pharma shares jump 17% on pending agreement over opioid litigation
09:54pm, Tuesday, 26'th Jul 2022 MarketWatch
Teva ADRs jump 17% to $8.31 late Tuesday after the company reaches agreement in principle to resolve the majority of its opioid-related litigation.
Why Teva Pharmaceuticals Stock Is Soaring After Hours
09:40pm, Tuesday, 26'th Jul 2022 Benzinga
Teva Pharmaceutical Industries (NYSE: TEVA) shares are surging in Tuesday's after-hours session after the company reported better-than-expected financial results.
Teva said second-quarter revenue decr
Teva reaches proposed $4.25 billion settlement of U.S. opioid lawsuits
05:11pm, Tuesday, 26'th Jul 2022
Teva Pharmaceutical Industries announced a $4.25 billion proposed nationwide settlement on Tuesday that could resolve thousands of lawsuits over the drugmaker's alleged role in the U.S. opioid epidemi
Drug, Biotech Stocks' Q2 Earnings on Jul 27: BMY, GSK & More
03:04pm, Tuesday, 26'th Jul 2022 Zacks Investment Research
Let's look what is in store for the four drug, biotech companies slated to release quarterly results tomorrow- BMY, GSK, ALKS, TEVA
Drug, Biotech Stocks' Q2 Earnings on Jul 27: BMY, GSK & More
12:25pm, Tuesday, 26'th Jul 2022
Let's look what is in store for the four drug, biotech companies slated to release quarterly results tomorrow- BMY, GSK, ALKS, TEVA
5 Stocks I'm Betting the Farm On
09:21am, Thursday, 21'st Jul 2022 The Motley Fool
Despite owning 44 stocks, I have 62.5% of my invested assets in just five companies.
5 Stocks I'm Betting the Farm On
05:21am, Thursday, 21'st Jul 2022
Despite owning 44 stocks, I have 62.5% of my invested assets in just five companies.
With Brighter Outlook, Generics Could Be Ripe for Investment
04:26pm, Monday, 18'th Jul 2022
Of the top 10 generic drugmakers in 2021, only one scored an increase in share price during the past year. It was Sun Pharmaceutical Industries Ltd.
San Francisco reaches $54 million opioid settlement with Teva and Allergan
10:27am, Tuesday, 12'th Jul 2022
Teva Pharmaceutical Industries Inc and AbbVie's Allergan business unit reached a $58 million opioid settlement with the city of San Francisco over claims that they fueled an opioid epidemic in the cit
2 Biotech Stocks That Could Soar in the Third Quarter
09:41am, Saturday, 02'nd Jul 2022 The Motley Fool
Bristol Myers Squibb and Bluebird Bio have drugs in their pipelines that could soon earn FDA approval.
